Clinical Trial Update: Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy [NA]

View source ↗

Summary

The document reports an interim imaging-focused update on a trial of anti-PD-1 therapy in metastatic melanoma, noting ongoing recruitment and use of FDG PET-CT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 inhibitor (unspecified)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Metastatic Melanoma | NA | Status: RECRUITING